The Neuro interventional Devices Market is specifically concerned with relation to devices and technologies to diagnose and treat diseases of the cerebral blood vessels. These devices help in performing surgeries that are noninvasive, which help the surgeons to treat neurological disorders such as aneurysm and stroke, and arteriovenous malformations without having to surgically open the patient’s body. Huge investment in products such as embolic coils, stents, and thrombectomy device that can positively impact on the patient’s results, shorten the recovery time and mitigate procedural complications.

Neuroendocrine tumor lenitive market has been growing rapidly in the recent past due to rising incidence of NET in the world. New diagnostic technologies and molecular markers detect diseases before the onset of symptoms, increasing the need for therap Author ‘s note The development of highly sensitive imaging and biomarker detection technologies contributes to the early diagnosis of diseases which have been never manifested, and thus, increases the need for adequate treatment.

Neurological biomarkers are bio-active markers that may be detected in the brain, blood or cereal fluid to establish diagnosis of neurological disorders including Alzhiemers disease, Parkinson’s disease, Multiple sclerosis among other injuries. These biomarkers help in delineation of the disease process, diagnosis, prognostic assessment, and therapeutic outcome prediction.